Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Mar 08, 2019
- Cancer genomics: Mayo Clinic Radio Health Minute
Mayo Clinic, March 5, 2019 - Assessing long-term survival benefits of immune checkpoint inhibitors using the net survival benefit.
Péron Julien et al. Journal of the National Cancer Institute 2019 Mar - Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
Ali Aesha I et al. Frontiers in oncology 2019 56 - Genomic correlates of response to immune checkpoint blockade
TE Keenan et al, Nature Rev Genetics, March 6, 2019 - Proteomic and genomic profiling of pancreatic cancer.
Ansari Daniel et al. Cell biology and toxicology 2019 Feb - Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
HP Mohammad et al, Nature Medicine, March 6, 2019 - The microbiome, cancer, and cancer therapy
BA Helmink et al, Nature Medicine, March 6, 2019 - A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.
Gao Ze et al. PloS one 2019 14(3) e0211491 - Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Sokic-Milutinovic Aleksandra et al. Digestive diseases (Basel, Switzerland) 2019 Mar 1-6 - Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Wang Zhijie et al. JAMA oncology 2019 Feb - Automatic Genetic Risk Assessment Calculation Using Breast Cancer Family History Data from the EHR compared to Self-Report.
Sin Margaret et al. AMIA ... Annual Symposium proceedings. AMIA Symposium 2018 2018970-978 - Clinical models of telehealth in genetics: A regional telegenetics landscape.
Terry Alissa B et al. Journal of genetic counseling 2019 Mar - Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
Swellam Menha et al. Journal of cellular biochemistry 2019 Mar - Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns.
Peters Matthew et al. Journal of global oncology 2019 Feb 51-7 - Correlation of a Commercial Genomic Risk Classifier with Histologic Patterns in Prostate Cancer.
Greenland Nancy Y et al. The Journal of urology 2019 Feb 101097JU0000000000000175
.png)
No hay comentarios:
Publicar un comentario